RxDoctor Payments Data

Rouzbeh Motiei Langroudi, MD

Neurological Surgery · Lexington, KYNPI 1497285886

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $21,060 of the $25,471 with a category attached, or 82.7%. Medical Device Business Services, Inc. accounts for 94.1% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $12,158 and has fallen 59.9% since, to $4,873 in 2025.

$25,471in general payments, 2019–2025

Across 49 payments — averaging $519.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$24K
  • Johnson & Johnson$1K
  • Icotec Medical Inc.$112
  • MIS Technologies, LLC$65
  • Centinel Spine, LLC$58
  • Medtronic$41
  • plus $14 from 1 others
$18,373in research payments, 2019–2025

Across 2 payments — averaging $9186.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Tanabe Pharma America, Inc.$10K
  • Mitsubishi Tanabe Pharma Development America, Inc.$9K

What the payments were for

  • Consulting fees$21,06083%
  • Travel & lodging$2,1558%
  • Food & beverage$2,2569%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medical Device Business Services, Inc.26$23,956
Johnson & Johnson(2 entities)17$1,226
Icotec Medical Inc.1$112
MIS Technologies, LLC1$65
Centinel Spine, LLC1$58
Medtronic2$41
Depuy Synthes Products, Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,471 in reported general payments places this provider in the 80th percentile of 99 neurological surgery providers in Kentucky.

See all neurological surgery providers in Kentucky

Medicare billing

Part B allowed, 2024
$220,350
Medicare patients
217
Services billed
623

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl85$574
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen35$247
Gabapentin15$131
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen15$90
Cyclobenzaprine Hcl21$86
Diazepam34$55

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →